Current bronchiolitis management guidelines [1] suggest that viral testing is not necessary in children admitted with symptoms of bronchiolitis, but bronchiolitis is a clinical diagnosis that has many ...
Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar submucosal ...
Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol ...
Bronchiolitis is defined as an acute inflammation of bronchioles in the lower respiratory tract that results in airway obstruction with accompanying progressive dyspnea and poor feeding. This ...
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Bronchiolitis ...
A new study supports the safety of the common painkillers acetaminophen and ibuprofen in the first year of life, and finds no ...
Please provide your email address to receive an email when new articles are posted on . Infants who experience bronchiolitis during respiratory syncytial virus season within their first 6 months of ...
Ziresovir significantly improved clinical outcomes and reduced RSV viral load in infants compared to placebo in a phase 3 trial. The trial involved infants aged 1 to 24 months, with ziresovir showing ...
This page lists all known medications that could potentially lead to 'Bronchiolitis' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s ...
The consultation files of the author were searched for all cases referred to the author in consultation as possible ‘nonspecific interstitial pneumonia’ from 2000 to 2006. Of these 32 cases, nine ...
DelveInsight’s Bronchiolitis Obliterans Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, bronchiolitis obliterans syndrome emerging drugs, market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results